Patient Capital Management praises Carvana Co.'s strong performance and growth in the used car market.

From Yahoo Finance: 2025-04-24 07:45:00

Patient Capital Management released its Q1 2025 investor letter, reporting a -9.5% return compared to the S&P 500’s -4.3%. The portfolio’s performance was positively impacted by allocation and interaction effects but partially offset by selection effects. Carvana Co. (NYSE:CVNA) was highlighted in the letter, with a one-month return of 8.33% and a market capitalization of $25.838 billion.

In the Q1 2025 letter, Patient Capital Opportunity Equity Strategy discussed Carvana Co. (NYSE:CVNA), noting the company’s focus on growth and innovation in the used car market. The company has achieved industry-leading EBITDA margins by leveraging their fixed cost base while enhancing the customer experience. The strategy initiated a position in Carvana Co. (NYSE:CVNA) during the quarter.

Carvana Co. (NYSE:CVNA) saw a surge in popularity among hedge funds, with 84 portfolios holding the stock at the end of Q4 2024 compared to 66 in Q3. While the potential of Carvana Co. (NYSE:CVNA) is acknowledged, the focus remains on AI stocks for higher returns. For more stock insights, check out the latest investor letters from hedge funds and leading investors.



Read more at Yahoo Finance: What Makes Carvana Co. (CVNA) an Investment Bet?